Beyond the Result Ep 6: The Payer Perspective - Driving Dx Stewardship and Smarter Coverage Policies

In our latest episode of Diasorin’s Beyond the Resultpodcast, host Angelo Rago discusses diagnostic stewardship and moleculardiagnostic reimbursement with Gabriel Bien-Willner, MD, PhD, Medical Directorof MolDX and Chief Medical Officer at Palmetto GBA. Highlights include: ·  Why laboratory tests need a Z identifier code rather than just a CPT code, and how MolDX pioneered a test registry that makes it easier for payers to understand each assay, the service rendered, and whenit’s appropriate for use.· Diagnostic stewardship fits neatly into the payer perspective of covering services that are reasonable and necessary. Most of the time, Bien-Willner says, providers, patients, and payers are in alignment about what should be done.· Payers have the power of the purse: their coverage determinations shape the landscape of which tests have staying power and which don’t.· For optimal utility, Bien-Willner says, coverage policies should be written in a way that allows them to be used for future tests. Credits: Host – Angelo Rago, President of Luminex division ofDiasorin Guest – Gabriel Bien-Willner, MD, PhD, Medical Directorof MolDX and Chief Medical Officer at Palmetto GBAProducers – Stephanie Ibbotson, Sr. Director of StrategicMarketing and Market Access and Michelle Tabb, PhD, Chief Scientific Officer Editor – Britta Good, Graphic Designer, Global Marketing  Sign up to be notified for new episodes:https://us.diasorin.com/en/molecular-diagnostics?utm_source=YouTube&utm_medium=YT-description&utm_campaign=Podcast&utm_id=Corporate&utm_term=Ep6